203 related articles for article (PubMed ID: 25597770)
1. Nanomedicine for targeted photothermal cancer therapy: where are we now?
Chen F; Cai W
Nanomedicine (Lond); 2015 Jan; 10(1):1-3. PubMed ID: 25597770
[No Abstract] [Full Text] [Related]
2. CuS nanoparticles: clinically favorable materials for photothermal applications?
Xiao Z
Nanomedicine (Lond); 2014 Mar; 9(3):373-5. PubMed ID: 24746188
[No Abstract] [Full Text] [Related]
3. What potential does plasmonics-amplified synergistic immuno photothermal nanotherapy have for treatment of cancer?
Vo-Dinh T; Inman BA
Nanomedicine (Lond); 2018 Jan; 13(2):139-144. PubMed ID: 29231126
[No Abstract] [Full Text] [Related]
4. Synergistic nanomedicine by combined gene and photothermal therapy.
Kim J; Kim J; Jeong C; Kim WJ
Adv Drug Deliv Rev; 2016 Mar; 98():99-112. PubMed ID: 26748259
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
[TBL] [Abstract][Full Text] [Related]
6. Gold nanocages for cancer detection and treatment.
Skrabalak SE; Au L; Lu X; Li X; Xia Y
Nanomedicine (Lond); 2007 Oct; 2(5):657-68. PubMed ID: 17976028
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for thermal cancer therapy.
Day ES; Morton JG; West JL
J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
[TBL] [Abstract][Full Text] [Related]
8. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
[TBL] [Abstract][Full Text] [Related]
9. Cancer nanomedicine: from drug delivery to imaging.
Chow EK; Ho D
Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
[TBL] [Abstract][Full Text] [Related]
10. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
Liang C; Xu L; Song G; Liu Z
Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
[TBL] [Abstract][Full Text] [Related]
11. Europe as leaders in nanomedicine: let's go for it!
Lévy L
Nanomedicine (Lond); 2014 Apr; 9(4):389-91. PubMed ID: 24787438
[No Abstract] [Full Text] [Related]
12. Nanoparticles for treatment of atherosclerosis: challenges of plasmonic photothermal therapy in translational studies.
Kharlamov AN; Zubarev IV; Shishkina EV; Shur VY
Future Cardiol; 2018 Mar; 14(2):109-114. PubMed ID: 29336170
[No Abstract] [Full Text] [Related]
13. Nanoparticles for cancer therapy using magnetic forces.
Tietze R; Lyer S; Dürr S; Alexiou C
Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of magnetic nanoparticles for hyperthermia.
Thiesen B; Jordan A
Int J Hyperthermia; 2008 Sep; 24(6):467-74. PubMed ID: 18608593
[TBL] [Abstract][Full Text] [Related]
15. Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat.
Campbell RB
Nanomedicine (Lond); 2007 Oct; 2(5):649-52. PubMed ID: 17976026
[No Abstract] [Full Text] [Related]
16. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
17. Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics.
Zou L; Wang H; He B; Zeng L; Tan T; Cao H; He X; Zhang Z; Guo S; Li Y
Theranostics; 2016; 6(6):762-72. PubMed ID: 27162548
[TBL] [Abstract][Full Text] [Related]
18. Tumor blood perfusion-based requirement of nanoparticle dose-loadings for plasmonic photothermal therapy.
Soni S; Sinha RK
Nanomedicine (Lond); 2019 Jul; 14(14):1841-1855. PubMed ID: 31267842
[No Abstract] [Full Text] [Related]
19. Plasmonic photothermal therapy for atheroregression below Glagov threshold.
Kharlamov AN
Future Cardiol; 2013 May; 9(3):405-25. PubMed ID: 23668744
[TBL] [Abstract][Full Text] [Related]
20. BSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo.
Zhang C; Fu YY; Zhang X; Yu C; Zhao Y; Sun SK
Dalton Trans; 2015 Aug; 44(29):13112-8. PubMed ID: 26106950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
